Table II.
Case | Treatment |
---|---|
1 | S-1 > EBRT > KORTUC-IORT > GEM+S-1 |
2 | EBRT > GEM > KORTUC-IORT > GEM+S-1 |
3 | GEM+S-1 > KORTUC-IORT > EBRT+GEM > GEM |
4 | GEM+S-1 > KORTUC-IORT > EBRT+GEM > GEM+S-1 |
5 | GEM > KORTUC-IORT > EBRT+GEM > GEM+S-1 |
6 | GEM > KORTUC-IORT > EBRT+GEM > GEM+S-1 |
7 | GEM > KORTUC-IORT > EBRT+GEM > GEM+S-1 |
8 | KORTUC-IORT > EBRT+GEM > GEM+S-1 |
9 | KORTUC-IORT > EBRT+GEM > GEM+S-1 |
10 | KORTUC-IORT > EBRT+GEM > GEM+S-1 |
11 | GEM > KORTUC-IORT > EBRT+GEM > GEM+S-1 |
12 | KORTUC-IORT > EBRT+GEM > GEM+S-1 |
>, followed by; S-1, tegafur, gimestat and otastat potassium; EBRT, external-beam radiotherapy; KORTUC, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas; IORT, intraoperative radiotherapy; GEM, gemcitabine hydrochloride.